1. Home
  2. GKOS vs LOPE Comparison

GKOS vs LOPE Comparison

Compare GKOS & LOPE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • LOPE
  • Stock Information
  • Founded
  • GKOS 1998
  • LOPE 1949
  • Country
  • GKOS United States
  • LOPE United States
  • Employees
  • GKOS N/A
  • LOPE N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • LOPE Other Consumer Services
  • Sector
  • GKOS Health Care
  • LOPE Real Estate
  • Exchange
  • GKOS Nasdaq
  • LOPE Nasdaq
  • Market Cap
  • GKOS 5.1B
  • LOPE 4.9B
  • IPO Year
  • GKOS 2015
  • LOPE 2008
  • Fundamental
  • Price
  • GKOS $89.91
  • LOPE $196.10
  • Analyst Decision
  • GKOS Strong Buy
  • LOPE Buy
  • Analyst Count
  • GKOS 13
  • LOPE 3
  • Target Price
  • GKOS $135.15
  • LOPE $201.00
  • AVG Volume (30 Days)
  • GKOS 1.1M
  • LOPE 230.2K
  • Earning Date
  • GKOS 04-30-2025
  • LOPE 05-06-2025
  • Dividend Yield
  • GKOS N/A
  • LOPE N/A
  • EPS Growth
  • GKOS N/A
  • LOPE 11.24
  • EPS
  • GKOS N/A
  • LOPE 7.94
  • Revenue
  • GKOS $404,523,000.00
  • LOPE $1,047,637,000.00
  • Revenue This Year
  • GKOS $27.84
  • LOPE $7.45
  • Revenue Next Year
  • GKOS $27.88
  • LOPE $6.67
  • P/E Ratio
  • GKOS N/A
  • LOPE $24.71
  • Revenue Growth
  • GKOS 23.92
  • LOPE 6.31
  • 52 Week Low
  • GKOS $77.10
  • LOPE $130.69
  • 52 Week High
  • GKOS $163.71
  • LOPE $192.18
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 45.80
  • LOPE 71.06
  • Support Level
  • GKOS $84.26
  • LOPE $183.54
  • Resistance Level
  • GKOS $92.27
  • LOPE $202.28
  • Average True Range (ATR)
  • GKOS 3.94
  • LOPE 4.90
  • MACD
  • GKOS 0.57
  • LOPE 2.06
  • Stochastic Oscillator
  • GKOS 58.87
  • LOPE 81.91

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

About LOPE Grand Canyon Education Inc.

Grand Canyon Education Inc is a publicly traded education services company dedicated to serving colleges and universities. GCE's university partner is Grand Canyon University, an Arizona non-profit corporation that operates a comprehensive regionally accredited university that offers graduate and undergraduate degree programs, emphases, and certificates across nine colleges both online, on the ground at its campus in Phoenix, Arizona and at four off-site classroom and laboratory sites. The Company generates all of its revenue through services agreements with its university partners.

Share on Social Networks: